Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Post by Goldnboy1on Mar 01, 2021 12:33am
252 Views
Post# 32683333

Anyone else see prodigious potential?

Anyone else see prodigious potential?

I think it's safe to say incoming subsidiary CEO. Dr. Ben Krantz is a prodigy. 


Arts Degree - University of Pennsylvania 

Masters of Business Admin - Tufts Univerity

Doctor of Medicine - Tufts University 

Residency - Internal Medicine Columbia Medical Centre

Fellow - Columbia Medical Centre Tech Ventures

Chief Fellow - Hematology/Oncology NYU 

 

Tufts is routinely ranked the number 1 or 2 school in Biology in America. Columbia Medical Centre goes without saying. Ivey league stuff.

People like this. Do not run $7m penny stocks. They run stocks several, and I mean several multiples higher. 

Hang on tight all. This is going to be one fun ride!!

<< Previous
Bullboard Posts
Next >>